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Soluble or particle-bound immune complexes containing the Fc domains of certain 
antibody subclasses, and cleavage products of the third component of complement 
interact with highly specific Fc and complement receptors on the surfaces of cells of 
the immune system. When these interactions occur on the surfaces of phagocytic 
leukocytes, they stimulate the selective release of lysosomal enzymes (1, 2), the 
expression of cell-mediated cytotoxic effects (3, 4), and the attachment and ingestion 
of particulate materials (5, 6, 7). 
During phagocytosis of antibody- or complement-coated particles, the advancing 
plasma membrane of the phagocyte is guided by the interaction of its receptors with 
ligands on the surface of the particle (8, 9). The advancing membrane pseudopods 
and the resulting phagocytic vacuole conform precisely to the geometry of the 
particle's urface. These findings suggest hat there is an excellent correspondence 
between the distribution of receptors on the membrane of the phagocyte and ligands 
on the surface of the particle. Particles with rigid cell walls such as bacteria or yeast, 
provide an immobile framework for antibody or complement molecules bound to 
them. The efficient interaction of membrane receptors with such immobilized ligands 
requires that the receptors have considerable ateral mobility within the plane o f  the 
phagocyte's membrane. 
By using muhivalent ligands such as antibodies or lectins, the movement of cell- 
surface molecules into caps has been demonstrated (10-13). Similarly, the attachment 
of antibody- or complement-coated particles to lymphocytes and monocytes results in 
the redistribution of the corresponding receptor sites (14, 15). Although the mecha- 
nism(s) that govern the movements of externally disposed membrane proteins are 
incompletely understood, there is vidence that the lateral movement of these mem- 
brane proteins is regulated by the contractile proteins of the cell (16, 17, 18). In 
addition, transmembrane associations of surface proteins with cytoskeletal elements 
are probably important forcell motility and cell spreading, and the remodeling of the 
plasma membrane during these activities (19, 20). 
The spreading of a phagocyte on ligand-coated surfaces is analogous in many 
respects to the ingestion of ligand-coated particles (21, 22). The surface may be 
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considered a giant particle for this purpose. Geometrically fixed ligands such as 
antibody-antigen complexes or complement on a culture-dish surface should induce 
cellular responses imilar to those occurring during ingestion of particles coated with 
the same ligands. Moreover, the ligand-coated surface provides an opportunity to 
functionally polarize the cell's membrane into two domains: a surface-adherent 
domain within which specific receptors may be focused and engaged by the corre- 
sponding ligands on the dish surface, and a nonadherent domain whose composition 
may be altered as a result of ligand-receptor interaction in the adherent domain. By 
studying the properties of  the nonadherent portion of the cell surface, it should be 
possible to analyze the effects of surface-adherent ligands on receptor localization and 
mobility. That such effects occur was first reported by Rabinovitch et al. (23) who 
showed that macrophages plated on antibody-antigen complexes lose the capacity to 
ingest, but not to bind, IgG-coated erythrocytes. The presence of complement in the 
substrate adherent immune complexes, however, did not appear to alter the capacity 
of macrophages to bind complement-coated erythrocytes (24, 25). 
We have developed a simple technique for homogeneously coating glass coverslips 
and plastic Petri dishes with a variety of immune complexes containing antibodies, or 
antibodies and complement. Macrophages plated on these surfaces exhibit ligand- 
specific modulation of their membrane receptors for immunoglobulins and for com- 
plement. Our  results indicate that surfaces coated with these ligands are powerful 
tools for dissecting the mechanisms that control receptor movement, and the config- 
uration of the ligands that regulate these activities. They further show that the 
membranes of macrophages plated onto such ligand-coated surfaces are functionally 
polarized into substrate-adherent and nonadherent domains. 
Mater ia ls  and  Methods  
Macrophages. Peritoneal macrophages were obtained as described (26) from NCS mice 
(Laboratory Animal Research Center, The Rockefeller University, New York) either by 
injecting phosphate-buffered saline deficient in Ca ++ and Mg ++ ions (PD) x (27) intraperitone- 
ally and collecting the cells (PC) immediately thereafter ( esident macrophages), or by injecting 
2 ml brewer's thioglycollate (Difco Laboratories, Detroit, Mich.) intraperitoneally and collectin~ 
the peritoneal exudate cells (PEC) after 4-5 d (thioglycollate-elicited maerophages). 4 × 10 
PC or 2 × 105 PEC were seeded into each 16-mm well of Costar plates (Costar, Data Packaging, 
Cambridge, Mass.). Each well contained a glass coverslip treated as described below, and 0.5 
ml Eagle's minimum essential medium with Earle's salt solution (MEM) (Grand Island 
Biological Co., Grand Island, N. Y.). The Costar plates were maintained for 30-60 min at 37°C 
in a 5% CO2-95% air mixture. The coverslips were washed free of nonadherent peritoneal cells, 
and transferred into 0.5 ml MEM in fresh Costar plates. 
Trypsinization of Peritoneal Cells. Peritoneal cells (4 × 106 cells/ml) in warm phosphate- 
buffered saline with Ca ++ and Mg ++ ions (PBS) (27), and containing 0.75 mg/ml trypsin 
(Worthington Biochemical Corp., Freehold, N.J.) and 0.025 mg/ml DNAase (Sigma Chemical 
Co., St. Louis, Mo.) were incubated in a plastic tube (Falcon No. 2057; Falcon Labware, Div. 
of Becton, Dickinson & Co., Oxnard, Calif.) at 37°C for 20 min on a rotating wheel (20 rpm). 
1 Abbreviations used in th spaper: BSA, bovine serum albumin; DNP, dinitrobenzene; E, sheep erythrocytes; 
E(IgG), E coated with rabbit anti-E IgG; E(IgG2a), E coated with monoclonal ouse anti-E IgG2a;. 
E(IgM)C, E coated with rabbit anti-E IgM and mouse complement; hFBS, heat-inactivated fetal bovine 
serum; HRP, horseradish peroxidase; HRP-GaR IgG, HRP-labeled goat IgG against rabbit IgG; MEM, 
Eagle's minimum essential medium with Earle's salt solution; PBS, phosphate-buffered saline with Ca ++ 
and Mg ++ ions; PC, resident mouse peritoneal cells; PD, PBS deficient in Ca ++ and Mg ÷÷ ions; PEC, 
mouse peritoneal exudate cells; PLL, poly-L-lysine; RaBSA IgG, rabbit anti-BSA IgG; RaDNP F(ab')2, 
F(ab')2 fragments of RaDNP IgG; RaDNP IgG, rabbit anti-DNP IgG; RaHRP IgG, rabbit anti HRP 
IgG; VBG, Veronal-buffered glucose with divalent cations 
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The digestion process was stopped with an equal volume of cold PD and 10% heat-inactivated 
(30 min, 56°C) fetal bovine serum (hFBS) (Flow Laboratories, Inc., Rockviile, Md.). The cells 
were washed once with PD and 10% hFBS, and once in PD alone, all at 2.5°C, and resuspended 
in cold MEM at a concentration f 4 × 106 PC/ml or 2 × 106 PEC/mi. Cells were >95 viable 
as examined by trypan blue (Grand Island Biological Co.) (28 exclusion after each trypsini- 
zation. The average cell recovery of trypsinized cells was 60%. Cells exposed to the same 
treatments inabsence of trypsin showed an average c ll recovery of 82% with >95% of the cells 
viable. 
Preparation of Coverslips. Glass coverslips of 12-mm Diam (SGA Scientific, Inc., Bloomfield, 
N. J.) were treated overnight at room temperature with chromerge (Manostat Corp., New 
York) dissolved in concentrated sulfuric acid, and washed for 2-4 h in running water followed 
by 1 h in distilled water. At this point, the coverslips were either dried, and stored as ready for 
use, or dried, and incubated in PD containing 0.1 mg/ml poly-L-lysine (PLL) (mol wt, ~70,000; 
Miles Laboratories Inc., Miles Research Products, Elkhart, Ind.) for 30 min at room tempera- 
ture. The PLL-coated coverslips were washed with PD, drained, and reacted with 16.8 mg/ml 
2,4-dinitrobenzene (DNP) sulfonate (Eastman Kodak Co., Rochester, N. Y.) in 0.15 M sodium- 
carbonate buffer (pH 11.6) for 30 min at room temperature. To bind bovine serum albumin 
(BSA) (Sigma Chemical Co.) or horseradish peroxidase (HRP) (Sigma Chemical Co.) the PLL- 
coated coverslips were first treated with 2.5% glutaraldehyde in PD for 15 rain at room 
temperature, washed extensively in distilled water followed by PD, and then reacted with 1 
mg/ml BSA or 10 mg/ml HRP in PD for 30 min at room temperature. To quench unreacted 
aldehyde groups, the coverslips were treated overnight at room temperature with 0.2 M glycine 
in 0.01 M sodium-phosphate buffer (pH 7.2). Samples of coverslip preparations that were 
assayed for bound HRP as described (29), demonstrated from 55 to 89 ng HRP linked to the 
surface of the coverslips. More than 90% of macrophages cultured in MEM on these coverslips 
for up to 4 h at 37°C in absence ofserum excluded trypan blue (28). 
Substrate-adherent a ibody-antigen complexes were formed by incubating PLL-DNP- 
coated coverslips with 9-13/~g of rabbit anti-DNP IgG (RaDNP IgG) in 60/~1 PBS for 30 min 
at room temperature. The coverslips were then washed with PD and used on the same day. In 
experiments o be reported elsewhere (J. Michl, M. M. Pieczonka, J. C. Unkeless, and S. C. 
Silverstein. Manuscript in preparation.), we found that this amount of Rc~DNP IgG had a 
maximal effect on Fc-receptor function. Untreated coverslips, and coverslips incubated with 
rabbit anti-BSA IgG (RaBSA IgG), RctDNP IgG, or with DNP alone served as controls. 
RaDNP IgG was produced in rabbits immunized with DNP-keyhole limpet hemocyanin i
complete Freund's adjuvant, and was purified by affinity chromatography by themethod of 
Eisen et al. (30), modified as described (31). F(ab')2 fragments of this antibody (RaDNP 
F[ab']2) were obtained by pepsin digestion f RaDNP IgG as described (32). RaBSA IgG was 
purified by DEAE-cellulose chromatography (33), and used at a concentration f 10-16/tg per 
coverslip. Rabbit anti-HRP IgG (Rc~HRP IgG) was a gift of Dr. M. L. Yarmush, The 
Rockefeller University. Immobilized BSA-RtxBSA IgG and HRP-RaHRP IgG complexes, 
respectively, were prepared following the procedure described above for the formation of 
substrate-adherent DNP-RaDNP IgG complexes. 
Complement-coated coverslips were prepared by incubating the PPL-DNP-RctDNP IgG- 
coated coverslips for 10 min at 37°C with 0.075 ml per coverslip of NCS mouse serum diluted 
1:1 in Veronal-buffered glucose (VBG) with divalent cations (34). The coverslips were then 
rinsed with PD (2.5°C) and used immediately for the seeding of peritoneal ceils. In control 
preparations heat-inactivated (30 min, 56°C) mouse serum was used instead of fresh mouse 
serum. 
Preparation of Particles. Sheep erythrocytes (E) (Laboratory Animal Research Center, The 
Rockefeller University) were coated with either rabbit anti-E IgG (Lot 50767, Cordis Labora- 
tories, Inc., Miami, Fla.) (E[IgG]) or with rabbit anti-E IgM (Lot 90906, Cordis Laboratories, 
Inc.) (E[IgM]) as described (7). The rabbit IgM was absorbed with Staphylococcus aureus to 
remove residual IgG (35). To prepare complement-coated E (E[IgM]C) the E(IgM) were further 
incubated with freshly thawed mouse serum (stored at -75°C) diluted 1:5 in VBG is described 
(7). Monoclonal mouse anti-E IgG2a, which was used to make E opsonized with a subagglutin- 
ating dose of monoclonal mouse anti-E IgG2a (E[IgG2a]), was prepared and kindly given to us 
by Diamond et al. (The Albert Einstein College of Medicine, Yeshiva University, New York) 
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(36). E(IgG), E(IgG2a), and E(IgM)C were adjusted to a final concentration f 2.5 X 10SE/ml 
PD by measurement of the hemoglobin concentration a d the use of a standard curve. 
Binding and Phagocytosis A say. Macrophages on coverslips were placed into 0.5 ml MEM in 
Costar wells. 0.1 ml of E(IgG) or E(IgM)C was added to each well and the complexes were 
incubated for 60 min at 37°C. The coverslips were then removed from the wells, dipped into 
PD to remove nonattached E from the macrophages, or treated with hypotonic buffer to lyse 
E that were attached but not ingested, and fixed in 1.25% glutaraldehyde in PD. The n.umber 
of E attached or ingested was determined by phase-contrast microscopy. At least 100 macro- 
phages in random fields were counted. The percentage of macrophages that attached or
ingested E multiplied by the average number of E attached or ingested per macrophage is 
expressed as ttachment and ingestion index, respectively. 
Electron Microscopy. 35-mm tissue-culture dishes (Falcon No. 3001; Falcon Labware, Div. of 
Becton, Dickinson & Co.) were coated with PLL-DNP as described above for cover slips 
omitting the chromerge-sulfuric a id treatment, and then incubated with 1 ml of PBS 
containing 0.28 mg of RaDNP IgG. To visualize the surface-adherent immune complexes these 
dishes were further incubated for 30 min at 2.5°C with HRP-labeled goat IgG against rabbit 
IgG (HRP-GaR IgG) (lot No. 11059, N. L. Cappel Laboratories Inc., CochranviUe, Pa.). The 
Petri dishes were washed by repeated ipping into cold PD. For controls, dishes coated with 
PLL alone or with PLL and DNP were overlaid with HRP-GaR IgG or the HRP-GaR IgG 
treatment was omitted. Staining for HRP was performed according to the method of Graham 
and Karnovsky (37) using diaminobenzidine (Sigma Chemical Co.) as substrate. 
For electron microscopy, 4 × 10 n PEC or 6-8 × 106 PC were plated for 30 rain at 37°C. 
The samples were processed as described (38), and the sections examined in a Philips 201 
electron microscope (Philips Electronic Instruments, Inc., Mahwah, N. J.). In some preparations 
the cells were mbedded in situ and sectioned perpendicularly to the dish surface to provide 
optimal views of the contact zone between macrophages and the immune-complex substrate, 
and of the macrophage surfaces not adherent to the dish. 
In parallel preparations, 2 × 106 PEC or 6 × 106 PC in MEM were cultured on control or 
immune complex-coated dishes, and the effect on attachment and ingestion of E(IgG) was 
examined. It was found that the results resembled the findings on the glass-coverslip prepara- 
tions. 
Resul ts  and  Discussion 
Effects of Immobilized Antibody-Antigen Complexes on Fc-Receptor Function. Thio- 
glycollate-elicited macrophages plated on coverslips coated with DNP-Rc~DNP IgG 
complexes exhibited a 68% reduction in attachment and a 97% reduction in ingestion 
of E(IgG). No inhibit ion of attachment or ingestion of E(IgG) was seen when 
macrophages were cultured on coverslips coated with PLL-DNP alone, or with PLL- 
DNP and RaDNP F(ab')2 (Table I). No significant alteration in Fc-receptor function 
was noted when macrophages were cultured on PeL-coated coverslips that had been 
incubated with RaDNP IgG, or on PeL-DNP-coated coverslips that had been 
incubated with RaBSA IgG. Qualitatively similar results were obtained when resident 
macrophages were substituted for thioglycollate-elicited macrophages in a parallel 
series of experiments. 
These results confirm the requirement for the Fc portion of antigen-specific IgG in 
the substrate-adherent immune complexes to induce paralysis of Fc-receptor-mediated 
phagocytosis (23). In addition, the decreased capacity of macrophages plated on 
antibody-antigen complex-coated surfaces to bind E(IgG) suggests that Fc receptors 
have been removed from, or inactivated on, the portion of the macrophage membrane 
not in contact with the substrate. 
Localization of Antibody-Antigen Complexes. One source of error in experiments with 
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TABLE I 
Effect of Immobilized Antibody-Antigen Complexes on Fc- and Complement-Receptor-mediated Ph gocytosis 
by ThioglycoUate-elicited Mouse Macrophages 
E(IgG) E(IgM)C 
Percent- Percent- Percent- Percent- 
Treatment of cover- age of age of age of age of 
slips coated with Attach- Inges- Attach- Inges- macro- macro- macro- macro- PLL-DNP ment in- tion in- ment in- tion 
phages dex phages dex phages dex phages index 
attach- ingest- attach- ingest- 
ing ing ing ing 
% % % % 
None 62 930 90 1,332 98 1,470 64 653 
RaDNP IgG 31 295 7 32 99 1,980 60 342 
RaDNP F(ab')2 90 744 93 791 ND ND 
RaBSA IgG 82 1,054 85 638 ND ND 
Preparation of coverslips, culture conditions, binding, and phagocytosis assays as described in Materials 
and Methods. 
ND, not done. 
immobi l ized l igands is that the effects observed may be due to the removal of the 
l igand from the substrate. Proteases ecreted by macrophages might release immune 
complexes from the coverslips into the medium. These soluble immune complexes 
might bind to and block the Fc receptor on the nonadherent membrane surface. 
Moreover, the immune complexes that b ind init ial ly to membrane receptors on the 
substrate-adherent surface might move in the plane of the membrane to the nonad- 
herent surface of the macrophage. Using a similar system, Rabinovi tch et al. (23) 
demonstrated that immune complexes were not released into the medium, and that 
soluble immune complexes added to the culture vessel were not responsible for the 
inhibit ion observed. However, they did not examine the possibil ity of movement of 
immune complexes in the plane of the membrane.  To resolve these issues unambig-  
ously we treated DNP-RaDNP IgG-coated Petri dishes with HRP-GaR IgG. After 
vigorous washing to remove loosely adsorbed IgG from the surfaces of the culture 
dishes, macrophages were plated on them, and incubated for 30 min at 37°C. As 
shown in the electron micrographs in Fig. 1, HRP-GaR IgG was found exclusively on 
the substrate-adherent cell surface. No peroxidase label was observed on the upper 
surface of the macrophages; in a few sections peroxidase label was seen in the 
macrophage cytoplasm in vacuoles directly adjacent o the substrate-adherent p lasma 
membrane.  These experiments demonstrate that the immune complexes are not 
released from the substrate, that they are not present on the upper surface of the 
macrophage,  and that they are not moved to other cellular compartments  during the 
course of these experiments. Thus, loss of Fc-receptor activity in macrophages p lated 
on DNP-RaDNP IgG-coated surfaces is not a result of Fc-receptor blockade by 
immune complexes bound to the port ion of the macrophage membrane that is not in 
contact with the substrate. 
Residual Fc-Receptor Activity. Mouse peritoneal macrophages express two Fc recep- 
tors: a protease-resistant Fc receptor that mediates b inding and ingestion of particles 
coated with aggregated rabbit  IgG or aggregated mouse IgG of subclasses 1 and 2b, 
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Fic. 1. Electron micrographs of unstained sections of resident mouse peritoneal macrophages 
cultured for 30 min at 37°C on DNP-RotDNP IgG and HRP-GaR IgG complexes. The macrophages 
adhere tightly to the peroxidase-labeled and diarninobenzidine-stained antibody-antigen compl xes 
on the dish surface. No peroxidase label can be found on the nonadherent surface of the cell body 
(a, b, and c) or on the extending pseudopods (b and d). Note the absence of stimulation of pi osome 
formation on the side of contact between macrophages and di h-adherent antibody-antigen com- 
plexes, and the presence of zones of organelle exclusion (a, arrow) which contain microfilaments 
running mostly parallel to the dish-surface-adherent plasma membrane (c). a and b, × 4,900; c, 
X 27,000; d, x 32,400. 
and a trypsin-sensitive Fc receptor that binds monomeric and aggregated mouse IgG 
of subclass 2a (IgG2a receptor) (36, 39, 40). Particles coated with rabbit IgG bind to 
both types of receptors (36, 39). Because in our experiments rabbit IgG was bound to 
antigens on the dish surface (Table I) and to the E used to assay for receptor activity, 
it was important to determine which of these receptors was responsible for the residual 
b inding of E(IgG) by macrophages plated onto DNP-RaDNP IgG complexes. 
To answer this question, and to examine the behavior of the protease resistant Fc 
receptors in the absence of the IgG2a receptor, macrophages were incubated with 
trypsin before plating (Fig. 2). Whereas trypsinization failed to affect the attachment 
of E(IgG) to macrophages on control coverslips, it reduced by >95% the binding of 
E(IgG) to macrophages plated onto DNP-RaDNP IgG-coated coverslips (Table II). 
These results indicate that trypsin-sensitive Fc receptors remain on the nonadherent 
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+ Trypsin 
A B 
Fic. 2. Model of the effect of trypsin on the Fc-receptor activity of macrophages plated onto rabbit 
IgG-antigen complexes. For further description see text. Symbols (']...1"), trypsin-resistant Fc 
receptor; ("~") trypsin-sensitive Fc receptor; (._~) surface-adherent antigen; ( ,~ ) rabbit IgG 
directed against the surface-adherent antigen. 
surface of macrophages plated onto rabbit antibody-antigen complexes; they suggest 
that these receptors are sponsible for the residual binding of E(IgG). When these Fc 
receptors are moved by trypsin treatment, no Fc receptors are left on the nonadher- 
ent surface of the phagocytes. 
To examine directly the presence or absence of the trypsin-sensitive Fc receptor 
that binds mouse IgG2a we used E(IgG2a). As shown in Table II, macrophages plated 
on control coverslips bound and ingested 8-10 E(IgG2a) each. In contrast most of the 
macrophages trypsinized in suspension before plating on control coverslips failed to 
bind or ingest any E(IgG2a), confirming that E(IgG2a) are selectively bound by the 
macrophages' trypsin-sensitive Fc receptors (36). 
Macrophages plated on DNP-RaDNP IgG complexes continued to bind and ingest 
E(IgG2a), albeit in markedly reduced numbers. However macrophages that had been 
trypsinized before plating on similarly coated coverslips neither bound nor ingested 
E(IgG2a). We propose the following model (Fig. 2) and explanation for these results: 
the presence of DNP-RaDNP IgG complexes on the surface of the coverslips induces 
the complete removal of trypsin-resistant Fc receptors from the nonadherent part of 
the macrophage plasma membrane (Fig. 2 B). These receptors mediate the phagocy- 
tosis of E coated with rabbit IgO (E[IgG]), and their removal results in the virtually 
complete inhibition of ingestion of these particles. The trypsin-sensitive Fc receptors 
for mouse IgG2a are incompletely modulated by the RaDNP IgG in the substrate- 
adherent immune complexes (Fig. 2A). Although we cannot explain the lack of 
complete modulation of IgG2a receptors by the substrate-adherent rabbit antibody- 
antigen complexes, it is evident hat IgG2a receptors are responsible for the residual 
binding of E(IgG) and the residual ingestion of E(IgG2a) by macrophages plated on 
rabbit antibody-antigen complexes. 
Complement-Receptor Modulation. To determine whether membrane receptors other 
than the Fc receptors are modulated when macrophages are plated on ligand-coated 
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TABLE II 
Effect of Trypsin on the Attachment and I gestion of E(IgG) and E(IgG2a) by Thioglycollate-elicited 




Treatment of coverxlips Treatment of age of Attach- age of age of Attach- age of 
coated with PIL-DNP macrophages macro- Ingestion macro- • 
ment in- macro- ment in- macro- 
phages dex phages index phages dex phages 
attach- attach- • 
ing ingesting ing ingesting 
Ingestion 
index 
None --  86 602 76 707 62 930 90 1,332 
RaDNP IgG --  32 173 26 135 31 295 7 32 
None Trypsin 14 70 19 72 74 518 84 924 
RaDNP IgG Trypsin 3 14 0 0 4 24 2 25 
E(lgG2a) were adjusted to 2~5 × 10 s E/ml in PD, and 0. l ml of this suspension was added to each Costar well. Trypsinization of macrophages, 
binding, and phagocytosis a says were performed asdescribed in Materials and Methods. 
surfaces, we xamined the effects of substrate-bound complement on complement- 
receptor activity of thioglycollate-elicited macrophages. Coverslips coated with DNP- 
RaDNP IgG were incubated with freshly thawed mouse serum as a complement 
source. Under these conditions, the immune complexes promote complement fixation 
to the surface of the coverslip. As expected (41), resident and thioglycollate-elicited 
macrophages rapidly spread out on these immune complex- and complement-coated 
coverslips. E(IgM)C were then added to these macrophages. As shown in Table III, 
line 2 and Table IV, line 3, there was a marked reduction in binding and ingestion of 
E(IgM)C when thioglycollate-elicited macrophages were plated on complement- 
coated coverslips. No decrease in complement-receptor activity was observed when 
thioglycollate-elicited marcophages were plated on DNP-RaDNP IgG-coated cover- 
slips that had been incubated with heat-inactivated mouse serum (Table III, line 5), 
or when DNP-coated coverslips were treated with RaBSA IgG or RaHRP IgG and 
fresh mouse serum (Table III, lines 5 and 6). Complement-receptor modulation was 
observed when thioglycollate-elicited macrophages were plated on coverslips treated 
with DNP, RaDNP F(ab')2 and fresh mouse serum. F(ab')2 antibody fragments 
promote complement fixation via the alternate pathway (42). Thus, surface-adherent 
antibody-antigen complexes and an active complement source are required to promote 
complement-receptor modulation in thioglycollate-elicited macrophages. Scharfstein 
et al., (43) have shown that antibody-antigen complexes bind complement components 
C3 and C4, but do not bind the terminal complement components C5-9. Because in 
the presence of fresh serum, both the activator, DNP-RaDNP IgG, of the classical 
complement pathway and the activator, DNP-RaDNP F(ab')2, of the alternative 
complement pathway promote complement-receptor modulation, we suggest that 
C3b bound to immune complexes on the substrate is responsible for this effect. 
Complement Receptors of Resident Macrophages Do Not Modulate. Both resident and 
thioglycollate-elicited mouse peritoneal macrophages possess a trypsin-sensitive mem- 
brane receptor for the third component of complement, C3b. The complement 
receptor of thioglycollate-elicited macrophages promotes both attachment and inges- 
tion of E(IgM)C. The complement receptor of resident macrophages mediates only 
the attachment of E(IgM)C (44). These differences in function of the complement 
receptors of resident and thioglycollate-elicited macrophages led us to search for 
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TABLE III 
Effect of Different Coverslip Preparations on the Modulation of the Complement Receptor f Thioglycollate- 
elicited Mouse Macrophages 




phages E(IgM)C at- 
with 





RaDNP IgG + mouse serum (C3b) 
RaDNP F(ab')2 + mouse serum (C3b) 
Mouse serum 
RaBSA IgG + mouse serum 
RaHRP IgG + mouse serum 
RotDNP IgG + mouse serum (30 rain, 56°C) 
% 
84 8 672 
26 6.5 169 
33 8 264 
72 10 720 
82 9.5 779 
78 9 702 
83 8 664 
Preparation of coverslips as described in Materials and Methods. The binding assay was performed with 
0.05 ml E(IgM)C added to each Costar well (concentration 2.5 x 108 E/ml in PD) for 1 h at 37°C. 
TABLE IV 
Effect of Complement-containing DNP-RaDNP IgG Complexes onComplement-Receptor Activity in 
Resident and Thioglycollate-elicited Mouse Macrophages 
Treatment of coverslips 
coated with PLL-DNP 
Resident macrophages Thioglycollate-elicited macrophages 
Percent- Percent- Percent- 
age of age of age of 
macro- Attach- macro- Attach- macro- 
phages ment index phages ment index phages 
with with with 
E(IgM)C E(IgM)C E(IgM)C 
attached attached ingested 
Ingestion 
index 
% % % 
None 85 1,105 91 1,365 84 798 
RaDNP IgG 94 705 96 1,055 80 928 
RaDNP IgG + mouse se- 84 1,176 30 222 31 133 
rum (C3b) 
Assay conditions as described in Materials and Methods. 
differences in receptor  modu la t ion  when these macrophages  were cu l tured  on com- 
p lement -coated  surfaces. Res ident  or th ioglycol late-el ic i ted macrophages  were p lated 
onto  complement -coated  coversl ips and  then incubated  with E ( IgM)C.  The  comple-  
ment - receptor  act iv i ty of  th ioglycol late-el ic i ted macrophages  was marked ly  reduced 
(Table IV). In contrast ,  there was no reduct ion in the a t tachment  of  E ( IgM)C  by 
resident macrophages.  As expected,  ingest ion of  E ( IgM)C  by resident macrophages  
was not observed. The  presence of  DNP or DNP-RaDNP IgG complexes on the 
coversl ips had no signif icant effect on the a t tachment  and ingest ion of  E ( IgM)C  by 
thioglycol late-el ic i ted macrophages ,  or on the b ind ing  o f  E ( IgM)C  by resident mac-  
rophages (Table IV). 
These f indings suggest that  there is a close corre lat ion between the capac i ty  of  
macrophages  to modu la te  their  membrane  receptors and the abi l i ty of  the receptors 
 o
n






Published September 1, 1979
616 EFFECTS OF IMMOBILIZED IMMUNE COMPLEXES 
TABLE V 
Fc-Receptor-mediated Phagocytosis in Thioglycollate-elicited Mouse Macrophages Cultured on Complement- 
containing DNP-RaDNP IgG Complexes 
Treatment ofcoverslips coated with PLL-DNP 
Percent- Percent- 
age of age of 
macro- Attach- macro- 







None 81 705 91 1,411 
RaDNP IgG 51 510 19 152 
RaDNP IgG + mouse serum (C3b) 92 1,215 98 1,353 
RaDNP IgG + mouse serum (30 min, 56°C) 50 530 12 52 
Assay conditions as described inMaterials and Methods. 
to mediate phagocytosis. Cells whose Fc receptors are modulated upon presentation 
of immobilized antibody-antigen complexes (resident and thioglycollate-elicited mac- 
rophages), or whose complement receptors are modulated upon presentation of 
complement-coated immune complexes (thioglycollate-elicited macrophages) phago- 
cytose particles coated with the corresponding li and. However, resident macrophages 
do not modulate their complement receptors in response to complement in the 
immobilized complexes and do not phagocytose E(IgM)C. 
Specificity of Receptor Modulation. To determine whether the effects of plating 
macrophages on one type of immobilized ligand affected binding of test particles 
coated with a different ligand, we examined complement-receptor function in thio- 
glycollate-elicited macrophages plated on DNP-RaDNP IgG complexes. As shown in 
Table I, no reduction in the capacity of these macrophages tO bind E(IgM)C was 
observed, and the proportion of macrophages that phagocytozed E(IgM)C was 
undiminished. The average number of E(IgM)C ingested by each macrophage, 
however, was decreased. Conversely, Fc-receptor function was unaffected when thio- 
glycollate-elicited macrophages were plated on DNP-RaDNP IgG-and-complement- 
coated surfaces; >90% of these macrophages bound and ingested 13-14 E(IgG) each 
(Table V, line 3). Thioglycollate-elicited macrophages plated on DNP-RaDNP IgG- 
coated coverslips that were not further treated, or that were treated with heated 
mouse serum showed marked reduction in binding, and an almost total inhibition of 
ingestion of E(IgG) (Table V, lines 2 and 4). These results indicate that substrate- 
adherent immune complexes affect only those receptors for which they act as ligands. 
Furthermore, they show that immobilized immune ligands do not cause a general 
paralysis of macrophage-receptor function. 
Although we do not know the mechanism(s) by which these receptors are modu- 
lated, it is important to point out that the receptors must move from the upper surface 
of the macrophage membrane before their interaction with ligands on the substrate. 
A similar situation has been described for the movement of surface immunoglobulins 
on motile lymphocytes (45). The capacity of these cells to modulate receptors that 
have not been complexed with ligands distinguishes these phenomena from ligand- 
induced lymphocyte capping (46), or the movement of concanavalin A binding sites 
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Flo. 3. Effect of the concentration of mouse serum used in the preparation of DNP-RaDNP IgG- 
and-complement-coated coverslips on Fc- and complement-receptor-mediated phagocytosis by 
thioglycollate-elicited macrophages. Parallel cultures of macrophages on the different coverslip 
preparations were incubated for 30 min at 37°C before being exposed to E(IgG) or E(IgM)C, 
respectively, as described in the text. (O), ingestion (Ing.) index, E[(IgM)C]; (0) ingestion i dex, 
lE(SgO)]. 
in dividing macrophage c ll lines (47). In these latter systems, receptors are modulated 
only when they are complexed by specific ligands. 
We were surprised to find Fc-receptor function unimpaired when macrophages 
were plated on DNP-Re~DNP IgG-coated coverslips that had been treated with fresh 
serum. To be certain that this reflected a general effect of serum on antigen-antibody 
complexes, we prepared coverslips coated with BSA-RaBSA IgG or with HRP-  
RaHRP IgG complexes, and incubated them with fresh mouse serum. Similar results 
were obtained. Thioglycollate-elicited macrophages plated on these coverslips ex- 
hibited a marked reduction in complement-receptor activity as measured by E(IgM)C 
ingestion, but retained full Fc-receptor function as measured by phagocytosis of 
E(IgG) (data not shown). Thus, the failure of DNP-RaDNP IgG complexes treated 
with mouse serum to promote Fc-receptor modulation is not a unique property of this 
IgG preparation. The inability of heated mouse serum to block Fc-receptor modulation 
by these complexes (Table V, line 4) indicates that complement fixation is required 
to prevent he interaction of the Fc segments of substra{e-adherent a ibody-antigen 
complexes with macrophage Fc receptors. 
These results suggested that a reciprocal relationship might exist between the 
amount of complement fixed by substrate-adherent DNP-RaDNP IgG complexes 
and the capacity of these complexes to modulate rnacrophage Fc receptors. To 
examine this possibility, thioglycollate-elicited macrophages were plated on DNP- 
RaDNP IgG-coated coverslips that had been incubated with decreasing concentra- 
tions of fresh mouse serum. These macrophages were then tested for their ability to 
ingest E(IgG) or E(IgM)C. As shown in Fig. 3, coverslips incubated with high 
concentrations of serum inhibited complement-receptor function and had no effect on 
Fc-receptor activity. At lower serum concentrations, complement-receptor function 
was unimpaired while Fc-receptor activity was inhibited. The reciprocal relationship 
between the activities of the two receptors at intermediate serum concentrations was 
particularly striking. These findings support the concept of an i verse relationship 
between the amount of complement bound to the substrate-adherent antibody- 
antigen complexes and the capacity of these complexes to modulate Fc- and comple- 
ment-receptor function, and are in agreement with the model proposed in Fig. 4. 
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Antibody Antibody + Complement 
Fro. 4. Model for receptor modulation in thioglycollate-elicited macrophaiges: thioglycollate-elic- 
ited macrophages seeded onto immobilized antibody-antigen complexes (~)  modulate their Fc 
receptors (,J-'~) while their complement receptors (.~.a~) remain unperturbed, (A) of the drawing. 
Experimentally, this is indicated by a loss of attachment and ingestion of E(IgG) on the nonadherent 
membrane surface, while the macrophages continue to bind and phagocytize E(IgM)C. (B), the 
binding of complement ((]D) onto the immobilized immune complexes results in the modulation 
of the macrophages' complement (C3b) receptors from the cells' nonadherent plasma membrane. 
Complement masks the Fc domain of Ig, G ( ~I~ ) so that it cannot be recognized by the cells Fc 
receptors leaving them available throughout the plasma membrane. This is shown experimentally 
by the ability of thioglycollate-elicited macrophages to bind and ingest E(IgG) upon plating onto 
antibody-antigen-and-complement-coated coverslips. 
Scharfstein et al., (43) have shown that when antibody-antigen complexes are 
coated with complement they no longer bind staphylococcal protein A. The amount 
of inhibition of staphylococcal protein A binding was proportional to the amount of 
complement fixed by the complexes. Because staphylococcal protein A binds to the 
Fc portion of IgG (48) their results provide direct evidence that complement compo- 
nents mask the Fc segment. 
These findings raise two issues relevant o immunopathology: first, they suggest 
that in vivo, where complement is present in abundance, the Fc segments of IgG in 
immune complexes will be unavailable for binding to the Fc receptors oflymphocytes, 
macrophages, and polymorphonuclear leukocytes. Under these circumstances many 
of these cells' effector functions may be mediated principally by their complement 
receptors, and not by their Fc receptors. Second, they indicate a possible function for 
subclasses of IgG that do not fix complement. Particle- or antigen-bound noncomple- 
ment fixing antibodies hould retain the capacity to interact with leukocyte Fc 
receptors in the presence of complement, and thereby to mediate a specific subset of 
immune effector functions. 
Summary  
We have examined the Fc- and complement-receptor function of resident and 
thioglycollate-elicited mouse peritoneal macrophages plated on surfaces coated with 
rabbit antibody-antigen complexes and with complement. We derive four major 
conclusions from these studies. (a) The trypsin-resistant Fc receptors of resident and 
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thioglycollate-elicited macrophages are completely modulated when these cells are 
plated on rabbit antibody-antigen complexes. Residual Fc receptor activity is a result 
of the incomplete modulation of trypsin-sensitive IgG2a receptors. (b) The comple- 
ment receptors of thioglycollate-elicited macrophages, but not of resident macro- 
phages, are modulated when these cells are plated on complement-coated surfaces. 
The capacity of the two cell types to modulate their complement receptors i correlated 
with their ability to ingest complement-coated erythrocytes. (c) The complement and 
Fc receptors of both types of macrophages move independently of one another. (d) 
Complement masks the Fc segments of IgG in immune complexes thereby rendering 
them ineffective as ligands for macrophage Fc receptors. 
We gratefully acknowledge the expert technical help and patience of Ms. Judy Adams in the 
preparation of the electron micrographs, and we thank Miss Betty Broyles for typing the drafts 
of this manuscript. 
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